Dr. Renika Mcleod-Labissiere, MD
115 Waterbury Road, Prospect, CT 06712 • +1-504-555-9789
Medical Education: Accredited U.S. Medical School (Class of 2008)
What This Doctor Actually Performs: CMS Medicare Utilization & Prospect Percentiles
NPI #1578648606 • CBSA Regional • Family Practice
Dr. Renika Mcleod-Labissiere, MD (NPI #1578648606) practices Family Practice in Prospect, CT (06712) with sub-specialty concentration in 65 Active CMS HCPCS Codes, recording 1,974 annual CMS services across 114 distinct beneficiaries—placing this practice as a top-decile high-throughput specialist (99th percentile in Prospect) (+0.37σ vs CT state mean, 87.91th statewide percentile).
Granular CPT/HCPCS billing distribution at 115 Waterbury Road shows Dr. Renika Mcleod-Labissiere's primary concentration in Comprehensive Primary Care & Chronic Protocol Management (code 99214: 303x/yr, 99th local percentile) alongside Focused Acute & Preventive Primary Care Evaluation (99213: 224x/yr, $33–$48).
Uninsured and high-deductible cash patients visiting Dr. Renika Mcleod-Labissiere in Prospect (06712) face an estimated $209.00 initial evaluation fee at 115 Waterbury Road (hybrid in-clinic and telehealth video consults; 13-minute average reception wait; bedside manner 4.92/5 from 13 verified reports).
Credentialed as an MD specialist with 18 years post-graduation experience since completing medical school at an LCME/COCA institution (2008), Dr. Mcleod-Labissiere coordinates 65 Active CMS HCPCS Codes workups from 115 Waterbury Road (+1-504-555-9789).
Top 10% Family Practice volume leader in Prospect, CT
1,974 annual services across 114 beneficiaries
Standard deviations from CT Family Practice mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Comprehensive Primary Care & Chronic Protocol Management | 303 | 99th | $43 – $60 |
| 99213 | Focused Acute & Preventive Primary Care Evaluation | 224 | 95th | $33 – $48 |
| G0439 | Annual Wellness Biomarker & Preventive Screening Visit | 87 | 96th | $50 – $68 |
| 36415 | Routine Venipuncture Blood Biomarker Collection | 65 | 99.5th | $25 – $40 |
| 99204 | New Patient Primary Care Intake & Diagnostic Plan | 43 | 98th | $60 – $82 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (65 HCPCS billing breadth) | 1,253 | 99th | $45 – $65 |
Are you Dr. Renika Mcleod-Labissiere? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Prospect, CT:
<a href="https://dotmd.com/doctors/renika-mcleod-labissiere-md-prospect-ct-1578648606" title="Dr. Renika Mcleod-Labissiere, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1578648606.svg" alt="Dr. Renika Mcleod-Labissiere Family Practice Badge" width="280" height="72" /></a>
Dr. Renika Mcleod-Labissiere, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Mcleod-Labissiere National Provider Identifier | NPI #1578648606 (MD) | CMS NPPES Registry (06712) |
| Dr. Mcleod-Labissiere Prospect CMS Volume Rank | 99.00th Pct (1,974 CMS svcs; Z +0.369σ) | CMS Medicare Part B (CT Family Practice) |
| Fair Cash-Pay New-Patient Benchmark | $209.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Prospect, CT) |
| Waiting-Room Wait Time & Cash Friendliness | $209.00 avg paid • 13 min lobby wait | 13 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.92/5 Listening • 4.78/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Renika Mcleod-Labissiere
Dr. Mcleod-Labissiere Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Prospect, CT.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Renika Mcleod-Labissiere community threads and patient logs by age, biological sex, dosage, and treatment duration.